Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Anti-Tubercular Activity of Substituted 7-Methyl and 7-Formylindolizines and In Silico Study for Prospective Molecular Target Identification.

Venugopala KN, Tratrat C, Pillay M, Mahomoodally FM, Bhandary S, Chopra D, Morsy MA, Haroun M, Aldhubiab BE, Attimarad M, Nair AB, Sreeharsha N, Venugopala R, Chandrashekharappa S, Alwassil OI, Odhav B.

Antibiotics (Basel). 2019 Dec 3;8(4). pii: E247. doi: 10.3390/antibiotics8040247.

2.

Novel Series of Methyl 3-(Substituted Benzoyl)-7-Substituted-2-Phenylindolizine-1-Carboxylates as Promising Anti-Inflammatory Agents: Molecular Modeling Studies.

Venugopala KN, Al-Attraqchi OHA, Tratrat C, Nayak SK, Morsy MA, Aldhubiab BE, Attimarad M, Nair AB, Sreeharsha N, Venugopala R, Haroun M, Girish MB, Chandrashekharappa S, Alwassil OI, Odhav B.

Biomolecules. 2019 Oct 28;9(11). pii: E661. doi: 10.3390/biom9110661.

3.

Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.

Venugopala KN, Chandrashekharappa S, Pillay M, Abdallah HH, Mahomoodally FM, Bhandary S, Chopra D, Attimarad M, Aldhubiab BE, Nair AB, Sreeharsha N, Morsy MA, Pottathil S, Venugopala R, Odhav B, Mlisana K.

PLoS One. 2019 Jun 4;14(6):e0217270. doi: 10.1371/journal.pone.0217270. eCollection 2019.

4.

Greener synthesis of indolizine analogues using water as a base and solvent: study for larvicidal activity against Anopheles arabiensis.

Sandeep C, Venugopala KN, Gleiser RM, Chetram A, Padmashali B, Kulkarni RS, Venugopala R, Odhav B.

Chem Biol Drug Des. 2016 Dec;88(6):899-904. doi: 10.1111/cbdd.12823. Epub 2016 Sep 9.

PMID:
27440719
5.

Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents.

Venugopala KN, Govender R, Khedr MA, Venugopala R, Aldhubiab BE, Harsha S, Odhav B.

Drug Des Devel Ther. 2015 Feb 17;9:911-21. doi: 10.2147/DDDT.S73890. eCollection 2015.

Supplemental Content

Loading ...
Support Center